Is Asbury’s New Sandy Springs Support Hub Reshaping the Operating Model Behind ABG’s Investment Story?

• Asbury Automotive Group recently marked the grand opening of its renovated Dealership Support Center in Sandy Springs, Georgia, a modern corporate hub featuring collaborative workspaces, wellness rooms, an arcade-style game room and an on-site café, with renovations that began in 2025 and employees moving in as early as November 2025.
• The new center is set to add 350 jobs to the local community, underlining Asbury’s commitment to long-term infrastructure investment and workforce expansion as it refines its operating model.
• We’ll now explore how this new support center, and its 350 additional jobs, might influence Asbury Automotive Group’s broader investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 36 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Asbury Automotive Group Investment Narrative Recap

To own Asbury Automotive Group, you need to be comfortable with a dealership model that leans heavily on acquisitions, digital tools and high-margin service revenue, while managing leverage and integration risk. The Sandy Springs Dealership Support Center fits into this story as a long-term infrastructure and talent investment; it does not materially change the near term catalysts around acquisition integration or the key risks tied to debt levels and industry shifts toward digital and direct sales models.

Among recent updates, the ongoing share repurchase program stands out next to the new support center. In Q4 2025, Asbury bought back about US$50.0 million of stock, bringing total repurchases under the 2023 authorization to roughly US$330.3 million. For investors watching how management balances capital returns with acquisitions, integration spending and corporate infrastructure like Sandy Springs, this buyback activity sits right alongside the support center as part of the capital allocation story.

Yet behind the new jobs and modern offices, investors should still be watching the pressure that elevated leverage could place on Asbury’s financial flexibility and interest costs...

Read the full narrative on Asbury Automotive Group (it's free!)

Asbury Automotive Group's narrative projects $20.7 billion revenue and $635.3 million earnings by 2029. This requires 4.8% yearly revenue growth and about a $143 million earnings increase from $492.0 million today.

Uncover how Asbury Automotive Group's forecasts yield a $250.44 fair value, a 25% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts paint a tougher picture, assuming revenue of about US$20.2 billion and earnings near US$605 million by 2028, so it is worth asking whether the Sandy Springs expansion softens concerns about dealership relevance and parts and service resilience or instead reinforces worries about returns on physical assets in a market that could be moving faster toward online and EV focused models.

Explore 2 other fair value estimates on Asbury Automotive Group - why the stock might be worth just $250.44!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Asbury Automotive Group research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Asbury Automotive Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Asbury Automotive Group's overall financial health at a glance.

Want Some Alternatives?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Outshine the giants: these 20 early-stage AI stocks could fund your retirement.
• Uncover the next big thing with 32 elite penny stocks that balance risk and reward.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com